Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:36AM CDT
The Medical sector is expected to deliver 5.4% earnings growth on 10.5% higher revenues in the second quarter.
PRXL: 66.47 (-0.94), EVHC: 23.54 (-0.05), CRL: 87.04 (-1.40), HUM: 169.57 (-1.61)
Teladoc Gaining Scale in Telehealth Market, Risk Remains
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 8:32AM CDT
Teladoc (TDOC) is witnessing its business growing steadily with insurers and customers increasingly embracing telehealth
TDOC: 17.98 (+0.44), CDNA: 4.68 (-0.12), BIOC: 0.63 (-0.13), CRL: 87.04 (-1.40)
Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Mon Jul 11, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2016 financial results on Wednesday, August 3rd before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 3rd, at 8:30 a.m. ET.
CRL: 87.04 (-1.40)
Charles River Laboratories to Present at Jefferies and William Blair Conferences
BusinessWire - Mon Jun 06, 7:30AM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York on Wednesday, June 8th, at 10:00 a.m. EDT, and the William Blair 36th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 14th, at 1:30 p.m. CDT (2:30 p.m. EDT). Management will present an overview of Charles River's strategic focus and business developments.
CRL: 87.04 (-1.40)
Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna's Nonclinical Development Efforts for Novel mRNA Therapeutics
BusinessWire - Mon Jun 06, 7:00AM CDT
Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics(TM) and Charles River Laboratories International, Inc. (NYSE:CRL), a leading early-stage contract research organization (CRO), today announced a strategic collaboration to support Moderna's nonclinical discovery and development efforts. Charles River will be a key partner as Moderna continues to grow and advance its pipeline spanning multiple drug modalities and therapeutic areas, conducting nonclinical activities to progress development candidates through investigational new drug (IND)-enabling studies and into the clinic.
CRL: 87.04 (-1.40)
Charles River beats Street 1Q forecasts
Automated Insights - Wed May 04, 6:20AM CDT
WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported first-quarter earnings of $37.1 million.
CRL: 87.04 (-1.40)
Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations
BusinessWire - Wed May 04, 6:00AM CDT
--- First-Quarter GAAP Earnings per Share of $0.78and Non-GAAP Earnings per Share of $0.98 -
CRL: 87.04 (-1.40)
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
AIRM: 31.11 (-1.59), PRXL: 66.47 (-0.94), EBS: 30.47 (-0.50), CRL: 87.04 (-1.40), MOH: 57.02 (+0.86)
5 Stocks to Invest on Healthcare Rebound
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 10:42AM CDT
Healthcare stocks bounced back this month after being mostly out of favor during the first quarter.
AIRM: 31.11 (-1.59), PRXL: 66.47 (-0.94), EBS: 30.47 (-0.50), CRL: 87.04 (-1.40), MOH: 57.02 (+0.86)
Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Thu Apr 07, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4th before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 4th, at 8:30 a.m. ET.
CRL: 87.04 (-1.40)
CRL November 18th Options Begin Trading
DividendChannel.com - Mon Mar 21, 10:05AM CDT
Investors in Charles River Laboratories International Inc. saw new options begin trading today, for the November 18th expiration.
CRL: 87.04 (-1.40)
Charles River Laboratories to Present at Raymond James Conference
BusinessWire - Mon Mar 07, 7:30AM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 8th, at 10:25 a.m. ET. Management will present an overview of Charles River's strategic focus and business developments.
CRL: 87.04 (-1.40)
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance
BusinessWire - Wed Feb 10, 6:00AM CST
--- Fourth-Quarter GAAP Earnings per Share of $0.69 and Non-GAAP Earnings per Share of $1.00 -
CRL: 87.04 (-1.40)
PAREXEL International Q2 Earnings Beat, FY16 View Slashed
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 8:00AM CST
PAREXEL International Corp (PRXL) reported adjusted earnings of 90 cents per share in the second quarter of fiscal 2016, beating the Zacks Consensus Estimate by 19 cents.
PRXL: 66.47 (-0.94), INCR: 42.98 (+0.22), AHS: 42.61 (-0.70), CRL: 87.04 (-1.40)
Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
Zacks Equity Research - Zacks Investment Research - Fri Jan 22, 8:30AM CST
Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
AIRM: 31.11 (-1.59), INCR: 42.98 (+0.22), HWAY: 16.64 (-0.20), AHS: 42.61 (-0.70), CRL: 87.04 (-1.40)
Top Healthcare Stocks
Brian Bolan - ZACKS - Thu Jan 21, 2:17PM CST
Top Healthcare Stocks
AIRM: 31.11 (-1.59), HWAY: 16.64 (-0.20), INCR: 42.98 (+0.22), AHS: 42.61 (-0.70), CRL: 87.04 (-1.40)
Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference Call
BusinessWire - Wed Jan 20, 3:30PM CST
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2015 financial results and provide 2016 guidance on Wednesday, February 10th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 10th, at 8:30 a.m. ET.
CRL: 87.04 (-1.40)
New Strong Buy Stocks for January 19th
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
CNC: 68.86 (-0.58), CBG: 28.32 (-0.25), AAL: 33.51 (-2.09), CRL: 87.04 (-1.40), CAFD: 16.67 (+0.23)